Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States

被引：0
|
作者：
Pan, Xianying
Verma, Devashish
Zhang, Jiayin
Pathak, Raminder
Monda, Stefano
Ma, Xiaomei
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
736
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases
    Li, Wang
    Yu, Hong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 137 - 152
  • [32] Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases
    Wang Li
    Hong Yu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 137 - 152
  • [33] Clinical outcome of immune related hepatitis (IrHep) in patients with advanced melanoma (AM) treated with single agent or combination immune checkpoint inhibitors (ICIs)
    Shah, N.
    Puthiamadathil, J.
    Serzan, M. T.
    Belouali, A.
    Kelly, W. J.
    Ma, B.
    Blackburn, M.
    Knoedler, A.
    OchoaGonzaelz, S.
    Janni, M.
    Madhavan, S.
    Gibney, G. T.
    Atkins, M. B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Assessment of YouTube as an information source for immune checkpoint inhibitors (ICIs)
    Garg, Tulika
    Chahal, Rutvi
    Khosla, Atulya Aman
    Singh, Rohit
    Karass, Susan Hosny
    Sharma, Rakesh Kumar
    Roy, Arya Mariam
    Thakkar, Astha
    Jatwani, Karan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Vafaei, Somayeh
    Zekiy, Angelina O.
    Khanamir, Ramadhan Ado
    Zaman, Burhan Abdullah
    Ghayourvahdat, Arman
    Azimizonuzi, Hannaneh
    Zamani, Majid
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [36] Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs)
    He, Jiasen
    John, Ida
    Afridi, Faraz
    Sun, Mianen
    Wang, Yinghong
    Roth, Michael
    McQuade, Jennifer Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
    Hughes, Michael S.
    Molina, Gabriel E.
    Chen, Steven T.
    Zheng, Hui
    Deshpande, Vikram
    Fadden, Riley
    Sullivan, Ryan J.
    Dougan, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [38] Increased risk of immune-related hepatitis among adolescent and young adults (AYAs) with melanoma during immunotherapy with checkpoint inhibitors (ICIs).
    Darwin, Alicia
    Reed, Damon R.
    Tanvetyanon, Tawee
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Changes in the survival of adult patients with metastasized melanoma with the approval of immune checkpoint inhibitors: A retrospective study from the United States database
    Adhikari, Arjab
    Cha, Elaine
    Antala, Drashti
    Sapkota, Supriya
    Bhattarai, Utsuk
    CANCER EPIDEMIOLOGY, 2022, 81
  • [40] Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
    Naimi, Adel
    Mohammed, Rebar N.
    Raji, Ahmed
    Chupradit, Supat
    Yumashev, Alexei Valerievich
    Suksatan, Wanich
    Shalaby, Mohammed Nader
    Thangavelu, Lakshmi
    Kamrava, Siavash
    Shomali, Navid
    Sohrabi, Armin D.
    Adili, Ali
    Noroozi-Aghideh, Ali
    Razeghian, Ehsan
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
12345